These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 23558567)
1. K5/K14-positive cells contribute to salivary gland-like breast tumors with myoepithelial differentiation. Boecker W; Stenman G; Loening T; Andersson MK; Bankfalvi A; von Holstein S; Heegaard S; Lange A; Berg T; Samoilova V; Tiemann K; Buchwalow I Mod Pathol; 2013 Aug; 26(8):1086-100. PubMed ID: 23558567 [TBL] [Abstract][Full Text] [Related]
2. Squamous/epidermoid differentiation in normal breast and salivary gland tissues and their corresponding tumors originate from p63/K5/14-positive progenitor cells. Boecker W; Stenman G; Loening T; Andersson MK; Berg T; Lange A; Bankfalvi A; Samoilova V; Tiemann K; Buchwalow I Virchows Arch; 2015 Jan; 466(1):21-36. PubMed ID: 25344874 [TBL] [Abstract][Full Text] [Related]
3. Podoplanin is a novel myoepithelial cell marker in pleomorphic adenoma and other salivary gland tumors with myoepithelial differentiation. Tsuneki M; Maruyama S; Yamazaki M; Essa A; Abé T; Babkair HA; Ahsan MS; Cheng J; Saku T Virchows Arch; 2013 Mar; 462(3):297-305. PubMed ID: 23262786 [TBL] [Abstract][Full Text] [Related]
5. p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation. Foschini MP; Gaiba A; Cocchi R; Pennesi MG; Pession A Int J Surg Pathol; 2005 Oct; 13(4):329-35. PubMed ID: 16273188 [TBL] [Abstract][Full Text] [Related]
6. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential. Foschini MP; Krausz T Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833 [TBL] [Abstract][Full Text] [Related]
7. Carcinoma ex pleomorphic adenoma of minor salivary glands with major epithelial-myoepithelial component: clinicopathologic and immunohistochemical study of 3 cases. Sedassari BT; Dos Santos HT; Mariano FV; da Silva Lascane NA; Altemani A; Sousa S Ann Diagn Pathol; 2015 Jun; 19(3):164-8. PubMed ID: 25890488 [TBL] [Abstract][Full Text] [Related]
9. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Prasad AR; Savera AT; Gown AM; Zarbo RJ Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827 [TBL] [Abstract][Full Text] [Related]
10. Vimentin as a marker of myoepithelial cells in salivary gland tumors. de Araújo VC; de Araújo NS Eur Arch Otorhinolaryngol; 1990; 247(4):252-5. PubMed ID: 2165413 [TBL] [Abstract][Full Text] [Related]
11. WT1 as a myoepithelial marker: a comparative study of breast, cutaneous, and salivary gland lesions. Ng JKM; Li JJX; Lai BSW; Tsang JY; Chan AWS; Cheung CMT; Ip ECC; Tse GM Hum Pathol; 2023 May; 135():76-83. PubMed ID: 36739952 [TBL] [Abstract][Full Text] [Related]
12. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Edwards PC; Bhuiya T; Kelsch RD Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875 [TBL] [Abstract][Full Text] [Related]
13. Salivary gland-like tumours of the breast: surgical and molecular pathology. Pia-Foschini M; Reis-Filho JS; Eusebi V; Lakhani SR J Clin Pathol; 2003 Jul; 56(7):497-506. PubMed ID: 12835294 [TBL] [Abstract][Full Text] [Related]
14. Application of immunohistochemistry to the diagnosis of salivary gland tumors. de Araújo VC; de Sousa SO; Carvalho YR; de Araújo NS Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):195-202. PubMed ID: 10981871 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors. Huang JW; Ming Z; Shrestha P; Mori M; Ilg E; Schäfer BW; Heizmann CW J Oral Pathol Med; 1996 Nov; 25(10):547-55. PubMed ID: 8986967 [TBL] [Abstract][Full Text] [Related]
16. Normal and neoplastic myoepithelial cells in salivary glands: an immunohistochemical study. Morinaga S; Nakajima T; Shimosato Y Hum Pathol; 1987 Dec; 18(12):1218-26. PubMed ID: 2824327 [TBL] [Abstract][Full Text] [Related]
18. WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium. Langman G; Andrews CL; Weissferdt A Mod Pathol; 2011 Feb; 24(2):168-74. PubMed ID: 21057459 [TBL] [Abstract][Full Text] [Related]
19. Thomsen-Friedenreich (T) antigen as marker of myoepithelial and basal cells in the parotid gland, pleomorphic adenomas and adenoid cystic carcinomas. An immunohistological comparison between T and sialosyl-T antigens, alpha-smooth muscle actin and cytokeratin 14. Therkildsen MH; Mandel U; Christensen M; Dabelsteen E APMIS; 1995; 103(7-8):558-67. PubMed ID: 7576573 [TBL] [Abstract][Full Text] [Related]
20. The expression of alpha vascular smooth-muscle actin in salivary gland tumors. Hirano T; Gluckman JL; deVries EJ Arch Otolaryngol Head Neck Surg; 1990 Jun; 116(6):692-6. PubMed ID: 1692711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]